FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

1495581000168106: List of Medicines for Brand Consideration reference set (foundation metadata concept)


Status: current, Primitive. Date: 30-Sep 2020. Module: Third party reference set module

Descriptions:

Id Description Lang Type Status Case? Module
4462321000168116 List of Medicines for Brand Consideration reference set (foundation metadata concept) en Fully specified name Active Initial character case insensitive Third party reference set module
4462331000168118 List of Medicines for Brand Consideration reference set en Synonym Active Initial character case insensitive Third party reference set module
4462411000168119 List of Medicines for Brand Consideration (LMBC) reference set en Synonym Active Initial character case insensitive Third party reference set module
4462641000168118 <p>Supports the identification of AMT Medicinal Product Unit of Use (MPUU) and Medicinal Product Pack (MPP) concepts associated with the List of Medicines for Brand Consideration (LMBC) that forms part of the Active Ingredient Prescribing initiative. Under the <i>National Health (Pharmaceutical Benefits) Regulations 2017</i>, the <i>Repatriation Pharmaceutical Benefits Scheme Instrument 2013</i> and <i>MRCA Pharmaceutical Benefits Scheme Instrument 2013</i>, all PBS and RPBS prescriptions must be prepared by active ingredient, the brand may additionally be identified if a prescriber considers it necessary. The LMBC supports prescribers' decision-making regarding the inclusion of brand on a prescription.</p><p>This reference set can be used by prescribing software vendors to identify medications for brand consideration to meet Active Ingredient Prescribing requirements.</p><p><b>Target Client:&nbsp;</b>This reference set was developed by the National Clinical Terminology Service for the Australian Government Department of Health and Aged Care to support the Active Ingredient Prescribing initiative, and can be used by developers to assist with the requirements.</p> en Definition Active Case sensitive Third party reference set module


1324 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
List of Medicines for Brand Consideration reference set Is a Reference sets for Medications true Inferred relationship Some
List of Medicines for Brand Consideration reference set Is a Simple type reference set true Inferred relationship Some
List of Medicines for Brand Consideration reference set Developed by Australian Government Department of Health and Aged Care true Inferred relationship Some 1570063879

Members
budesonide 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation, 120 actuations
budesonide 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation, 2 x 120 actuations
budesonide 200 microgram / 1 actuation + formoterol fumarate dihydrate 6 microgram / 1 actuation powder for inhalation, 3 x 120 actuations (medicinal product pack)
budesonide 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation, 30 actuations
budesonide 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation, 60 actuations
budesonide 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation, actuation
budesonide 3 mg enteric capsule
budesonide 3 mg enteric capsule, 45
budesonide 3 mg enteric capsule, 9
budesonide 3 mg enteric capsule, 90
budesonide 3 mg modified release capsule
budesonide 3 mg modified release capsule, 100
budesonide 3 mg modified release capsule, 50 capsules (medicinal product pack)
budesonide 3 mg modified release capsule, 90
buprenorphine 1.4 mg + naloxone 360 microgram sublingual tablet
buprenorphine 1.4 mg + naloxone 360 microgram sublingual tablet, 28
buprenorphine 1.4 mg + naloxone 360 microgram sublingual tablet, 30
buprenorphine 1.4 mg + naloxone 360 microgram sublingual tablet, 7
buprenorphine 10 microgram/hour patch
buprenorphine 10 microgram/hour patch, 1
buprenorphine 10 microgram/hour patch, 2
buprenorphine 10 microgram/hour patch, 4
buprenorphine 100 mg/0.5 mL modified release injection, syringe
buprenorphine 100 mg/0.5 mL modified release injection, 0.5 mL syringe
buprenorphine 11.4 mg + naloxone 2.9 mg sublingual tablet
buprenorphine 11.4 mg + naloxone 2.9 mg sublingual tablet, 28
buprenorphine 11.4 mg + naloxone 2.9 mg sublingual tablet, 30
buprenorphine 11.4 mg + naloxone 2.9 mg sublingual tablet, 7
buprenorphine 128 mg/0.36 mL modified release injection, syringe
buprenorphine 128 mg/0.36 mL modified release injection, 0.36 mL syringe
buprenorphine 15 microgram/hour patch
buprenorphine 15 microgram/hour patch, 1
buprenorphine 15 microgram/hour patch, 2
buprenorphine 15 microgram/hour patch, 4
buprenorphine 16 mg/0.32 mL modified release injection, syringe
buprenorphine 16 mg/0.32 mL modified release injection, 0.32 mL syringe
buprenorphine 160 mg/0.45 mL modified release injection, syringe
buprenorphine 160 mg/0.45 mL modified release injection, 0.45 mL syringe
buprenorphine 2 mg + naloxone 500 microgram sublingual film
buprenorphine 2 mg + naloxone 500 microgram sublingual film, 28
buprenorphine 2 mg + naloxone 500 microgram sublingual tablet
buprenorphine 2 mg + naloxone 500 microgram sublingual tablet, 28
buprenorphine 2 mg + naloxone 500 microgram sublingual tablet, 7
buprenorphine 2 mg sublingual tablet
buprenorphine 2 mg sublingual tablet, 100
buprenorphine 2 mg sublingual tablet, 28
buprenorphine 2 mg sublingual tablet, 7
buprenorphine 2.9 mg + naloxone 710 microgram sublingual tablet
buprenorphine 2.9 mg + naloxone 710 microgram sublingual tablet, 28
buprenorphine 2.9 mg + naloxone 710 microgram sublingual tablet, 30
buprenorphine 2.9 mg + naloxone 710 microgram sublingual tablet, 7
buprenorphine 20 microgram/hour patch
buprenorphine 20 microgram/hour patch, 1
buprenorphine 20 microgram/hour patch, 2
buprenorphine 20 microgram/hour patch, 4
buprenorphine 200 microgram sublingual tablet
buprenorphine 200 microgram sublingual tablet, 20
buprenorphine 200 microgram sublingual tablet, 50
buprenorphine 24 mg/0.48 mL modified release injection, syringe
buprenorphine 24 mg/0.48 mL modified release injection, 0.48 mL syringe
buprenorphine 25 microgram/hour patch
buprenorphine 25 microgram/hour patch, 2
buprenorphine 25 microgram/hour patch, 4
buprenorphine 30 microgram/hour patch
buprenorphine 30 microgram/hour patch, 2
buprenorphine 30 microgram/hour patch, 4
buprenorphine 300 mg/1.5 mL modified release injection, 1.5 mL syringe
buprenorphine 300 mg/1.5 mL modified release injection, syringe
buprenorphine 32 mg/0.64 mL modified release injection, syringe
buprenorphine 32 mg/0.64 mL modified release injection, 0.64 mL syringe
buprenorphine 40 microgram/hour patch
buprenorphine 40 microgram/hour patch, 2
buprenorphine 40 microgram/hour patch, 4
buprenorphine 400 microgram sublingual tablet
buprenorphine 400 microgram sublingual tablet, 100
buprenorphine 400 microgram sublingual tablet, 28
buprenorphine 400 microgram sublingual tablet, 7
buprenorphine 5 microgram/hour patch
buprenorphine 5 microgram/hour patch, 1
buprenorphine 5 microgram/hour patch, 2
buprenorphine 5 microgram/hour patch, 4
buprenorphine 5.7 mg + naloxone 1.4 mg sublingual tablet
buprenorphine 5.7 mg + naloxone 1.4 mg sublingual tablet, 28
buprenorphine 5.7 mg + naloxone 1.4 mg sublingual tablet, 30
buprenorphine 5.7 mg + naloxone 1.4 mg sublingual tablet, 7
buprenorphine 64 mg/0.18 mL modified release injection, syringe
buprenorphine 64 mg/0.18 mL modified release injection, 0.18 mL syringe
buprenorphine 700 microgram + naloxone 180 microgram sublingual tablet
buprenorphine 700 microgram + naloxone 180 microgram sublingual tablet, 28
buprenorphine 700 microgram + naloxone 180 microgram sublingual tablet, 30
buprenorphine 700 microgram + naloxone 180 microgram sublingual tablet, 7
buprenorphine 8 mg + naloxone 2 mg sublingual film
buprenorphine 8 mg + naloxone 2 mg sublingual film, 28
buprenorphine 8 mg + naloxone 2 mg sublingual tablet
buprenorphine 8 mg + naloxone 2 mg sublingual tablet, 28
buprenorphine 8 mg + naloxone 2 mg sublingual tablet, 7
buprenorphine 8 mg/0.16 mL modified release injection, syringe
buprenorphine 8 mg/0.16 mL modified release injection, 0.16 mL syringe
buprenorphine 8 mg sublingual tablet
buprenorphine 8 mg sublingual tablet, 100 tablets (medicinal product pack)
buprenorphine 8 mg sublingual tablet, 28

Start Page 2 of 14 Next End


Reference Sets

Australian dialect reference set

Reference set descriptor

Back to Start